Cargando…
Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
FLT3 mutations are one of the most common genetic alterations in acute myeloid leukemia (AML) and are identified in approximately one-third of newly diagnosed patients. Aberrant FLT3 receptor signaling has important implications for the biology and clinical management of AML. In recent years, target...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515417/ https://www.ncbi.nlm.nih.gov/pubmed/36185253 http://dx.doi.org/10.3389/fonc.2022.996438 |